We offer a number of clinical trials for women with ovarian, uterine (endometrial) and cervical cancers. All attending physicians at Mount Sinai are co-investigators of trials, so any doctor can enroll patients. In addition, studies comparing different chemotherapy agents in various stages of disease are being conducted in uterine and ovarian cancer and there is a study of pre-operative imaging for cervical cancers. Mount Sinai trials also allow women with ovarian cancer free access to Avastin (Bevacizumab) in combination with standard chemotherapy for first-line and second-line therapy.
We participated in international clinical trials that led to the development of the HPV vaccine Gardasil (Merck), which was approved in 2006 for girls and young women to protect against cervical cancer, and we are currently working with drug companies on trials for a new vaccine.
To find a clinical trial, please visit http://www.mssm.edu/research/clinical-trials.